Cathy L. Melvin*, Melanie S. Jefferson, Gayenell S. Magwood, Ni’Asia E. Hazelton, Chanita Hughes-Halbert
Melvin et al. J Clin Transl Res 2021; 7(3):8
Published online: June 5, 2021
Abstract
Background & Aim. This systematic review aimed to 1) understand Stakeholder Awareness of benefits, risks, and likelihood of participating in precision medicine research and treatment and 2) identify effective Communication Strategies to increase awareness of precision medicine.
Relevance for Patients: Our review identified a limited number of studies to inform stakeholder understanding and use of precision medicine, indicating that more evidence on how to communicate with stakeholders about precision medicine is warranted.
DOI: http://dx.doi.org/10.18053/jctres.07.202103.008
Author affiliation
1. Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC
2. Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC3. College of Nursing, Medical University of South Carolina, Charleston, SC
*Corresponding Author
Cathy L. Melvin
Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston SC
Email: melvinc@musc.edu
Handling editor:
Michal Heger
Department of Pharmaceutics, Utrecht University, the Netherlands
Department of Pharmaceutics, Jiaxing University Medical College, Zhejiang, China
Downloads
Full text PDF
Review process file (118.2 KB)
